PSMAfore: A phase 3 study to compare 177 Lu-PSMA-617 treatment with a change in androgen receptor pathway inhibitor in taxane-naive patients with metastatic castration-resistant prostate cancer.
177 Lu-PSMA-617
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: PSMAfore: A phase 3 study to compare 177 Lu-PSMA-617 treatment with a change in androgen receptor pathway inhibitor in taxane-naive patients with metastatic castration-resistant prostate cancer. ### Output: 177 Lu-PSMA-617